Workflow
J&J(JNJ)
icon
Search documents
Johnson & Johnson (JNJ) Bernstein's 39th Annual Strategic Decisions Conference 2023 (Transcript)
2023-05-31 19:10
Johnson & Johnson (NYSE:JNJ) Bernstein's 39th Annual Strategic Decisions Conference 2023 May 31, 2023 10:00 AM ET Company Participants Joaquin Duato - CEO & Chairman Conference Call Participants Lee Hambright - Sanford C. Bernstein & Co. Lee Hambright Okay. We are live. Great. Thank you. So everybody, I'm Lee Hambright, U.S. medical device analyst at Bernstein. We are thrilled to host Johnson & Johnson, Chairman and CEO, Joaquin Duato. Thanks so much for being here. We're scheduled for a 50-minute fireside ...
J&J(JNJ) - 2024 Q1 - Quarterly Report
2023-04-27 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended April 2, 2023 or Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ☐ for the transition period from to Commission file number 1-3215 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 22-1024240 (State or other jurisdiction of (I.R.S. Em ...
J&J(JNJ) - 2023 Q1 - Earnings Call Presentation
2023-04-18 16:11
1st Quarter 2023 Earnings Call Cautionary Note on Forward-looking Statements This presentation contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things: future operating and financial performance, product development, market position and business strategy, and the anticipated separation of the Company’s Consumer Health business. The viewer is cautioned not to rely on these forward-looking statements. These statements are based on ...
J&J(JNJ) - 2023 Q1 - Earnings Call Transcript
2023-04-18 16:09
Johnson & Johnson (NYSE:JNJ) Q1 2023 Earnings Conference Call April 18, 2023 8:30 AM ET Company Participants Jessica Moore - VP, IR Joe Wolk - EVP & CFO Ashley McEvoy - EVP, Worldwide Chairman of MedTech Andrew White - Assistant General Counsel Conference Call Participants Chris Schott - JPMorgan Matt Miksic - Barclays Terence Flynn - Morgan Stanley Larry Biegelsen - Wells Fargo Louise Chen - Cantor Fitzgerald Josh Jennings - TD Cowen Geoff Meacham - Bank of America Danielle Antalffy - UBS Operator Good mor ...
Johnson & Johnson (JNJ) management presents at Barclays Global Healthcare Conference (Transcript)
2023-03-14 18:50
Johnson & Johnson (NYSE:JNJ) Barclays Global Healthcare Conference March 14, 2023 10:15 AM ET Company Participants Aldo Denti - Company Group Chairman, DePuy Synthes The Orthopedic Company Peter Menziuso - Company Group Chairman, Johnson & Johnson Vision Conference Call Participants Matt Miksic - Barclays Operator Matt Miksic So good morning, everybody. My name is Matt Miksic, I am the Medical Device Analyst here in US for Barclays. I am very pleased to have with us today J&J, from J&J, Aldo Denti, Company ...
Johnson & Johnson (JNJ) Presents at Cowen 43rd Annual HealthCare Conference (Transcript)
2023-03-07 20:12
Johnson & Johnson (NYSE:JNJ) Cowen 43rd Annual HealthCare Conference March 7, 2023 11:10 AM ET Company Participants Joe Wolk - EVP and CFO Jessica Moore - VP, IR Conference Call Participants Josh Jennings - Cowen Josh Jennings Josh Jennings from Cowen Medical Devices team. We're moving right through the medical devices track, but we are incorporating some medical device part of a consumer hybrid into this track. And thankfully, with the executive team from Johnson & Johnson. We have Executive Vice President ...
J&J(JNJ) - 2022 Q4 - Earnings Call Transcript
2023-01-24 18:21
Johnson & Johnson (NYSE:JNJ) Q4 2022 Results Conference Call January 24, 2023 8:30 AM ET Company Participants Jessica Moore - VP, IR Joaquin Duato - Chairman and CEO Joe Wolk - EVP and CFO Conference Call Participants Terence Flynn - Morgan Stanley David Risinger - SVB Securities Larry Biegelsen - Wells Fargo Chris Schott - JP Morgan Matt Miksic - Barclays Chris Shibutani - Goldman Sachs Louise Chen - Cantor Fitzgerald Operator Good morning and welcome to Johnson & Johnson’s Fourth Quarter 2022 Earnings Con ...
J&J(JNJ) - 2023 Q3 - Quarterly Report
2022-10-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended October 2, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission file number 1-3215 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 22-1024240 (State or other jurisdiction of incorpor ...
J&J(JNJ) - 2022 Q3 - Earnings Call Transcript
2022-10-18 12:30
Good morning and welcome to Johnson & Johnson's 3rd Quarter 2022 Earnings Conference Call. All participants will be in a listener mode until the question and answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect at this time. If you experience technical difficulties during the conference, you may press star zero to reach the operator. I will now turn the conference call over to Johnson & Johnson. You may begin. Please note that today's meeting may in ...
J&J(JNJ) - 2023 Q2 - Quarterly Report
2022-07-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended July 3, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission file number 1-3215 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 22-1024240 (State or other jurisdiction of incorporati ...